Get the Stockscreener App
1.105
1.77%
-0.025
Cardiol Therapeutics Inc stock is traded at $1.105, with a volume of 406.54K.
It is down -1.77% in the last 24 hours and up +3.74% over the past month.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
See More
Previous Close:
$1.13
Open:
$1.15
24h Volume:
406.54K
Relative Volume:
0.42
Market Cap:
$94.97M
Revenue:
-
Net Income/Loss:
$-21.65M
P/E Ratio:
-3.3273
EPS:
-0.3321
Net Cash Flow:
$-15.84M
1W Performance:
-9.02%
1M Performance:
+3.74%
6M Performance:
-2.63%
1Y Performance:
-40.64%
1-Day Range:
$1.095
$1.155
1-Week Range:
$1.09
$1.22
52-Week Range:
$0.7709
$2.24
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Compare CRDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.105 | 107.52M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
144.38 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.43 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.385 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.49 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
436.34 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Initiated | H.C. Wainwright | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jun-26-24 | Initiated | ROTH MKM | Buy |
| Apr-22-24 | Initiated | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc Stock (CRDL) Latest News
Is it time to cut losses on Cardiol Therapeutics Inc.July 2025 Institutional & Real-Time Stock Movement Alerts - newser.com
What insider purchases suggest about Cardiol Therapeutics Inc. (CT9) stockJuly 2025 Patterns & Stock Market Timing Techniques - newser.com
Historical volatility pattern of Cardiol Therapeutics Inc. visualizedOptions Play & Scalable Portfolio Growth Ideas - newser.com
Key metrics from Cardiol Therapeutics Inc.’s quarterly data2025 Analyst Calls & High Return Stock Watch Alerts - newser.com
Will Cardiol Therapeutics Inc. (CT9) stock recover faster than industryWeekly Trade Recap & Accurate Trade Setup Notifications - newser.com
Technical analysis overview for Cardiol Therapeutics Inc. stockWatch List & Free Risk Controlled Daily Trade Plans - newser.com
How Cardiol Therapeutics Inc. stock benefits from tech adoptionWeekly Gains Summary & Breakout Confirmation Trade Signals - newser.com
How Cardiol Therapeutics Inc. stock reacts to inflationary pressures2025 Risk Factors & Daily Chart Pattern Signals - newser.com
Top chart patterns to watch in Cardiol Therapeutics Inc.July 2025 Trends & Short-Term Swing Trade Alerts - newser.com
Real time social sentiment graph for Cardiol Therapeutics Inc.Trade Ideas & Long-Term Investment Growth Plans - newser.com
(CRDL) Investment Analysis (CRDL:CA) - news.stocktradersdaily.com
What analysts say about Cardiol Therapeutics Inc stockLarge Cap Stability Picks & Free Short-Term Trading Strategies - earlytimes.in
Advanced analytics toolkit walkthrough for Cardiol Therapeutics Inc.Risk Management & Technical Confirmation Alerts - newser.com
Is Cardiol Therapeutics Inc. stock poised for growth2025 Biggest Moves & Real-Time Sentiment Analysis - newser.com
Why Cardiol Therapeutics Inc. stock is seen as undervaluedWeekly Trade Report & Verified Stock Trade Ideas - newser.com
How Cardiol Therapeutics Inc. stock reacts to bond yieldsBond Market & Community Verified Watchlist Alerts - newser.com
Will Cardiol Therapeutics Inc. (CT9) stock see valuation expansionJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com
Using Python tools to backtest Cardiol Therapeutics Inc. strategiesTrade Exit Summary & Weekly High Potential Stock Alerts - newser.com
What market sentiment indicators show for Cardiol Therapeutics Inc. (CT9) stockJuly 2025 Weekly Recap & Free Daily Entry Point Trade Alerts - newser.com
How Cardiol Therapeutics Inc. stock responds to policy changesEarnings Overview Report & Weekly Watchlist of Top Performers - newser.com
Full technical analysis of Cardiol Therapeutics Inc. stockPortfolio Risk Summary & Expert Verified Stock Movement Alerts - newser.com
Can technical indicators confirm Cardiol Therapeutics Inc.’s reversalEarnings Beat & Safe Entry Zone Identification - newser.com
Is Cardiol Therapeutics Inc. stock dividend yield sustainableBreakout Watch & Risk Controlled Swing Trade Alerts - newser.com
How to Take Advantage of moves in (CRDL) (CRDL:CA) - news.stocktradersdaily.com
Can swing trading help recover from Cardiol Therapeutics Inc. losses2025 Big Picture & Scalable Portfolio Growth Ideas - newser.com
Is this a good reentry point in Cardiol Therapeutics Inc.2025 Stock Rankings & Expert Curated Trade Setups - newser.com
Cardiol Therapeutics Inc Stock (CRDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.17%
1.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):